398 related articles for article (PubMed ID: 33069882)
1. Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus.
Lake JE; Overton T; Naggie S; Sulkowski M; Loomba R; Kleiner DE; Price JC; Chew KW; Chung RT; Corey KE
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):256-268. PubMed ID: 33069882
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis With Liver Fibrosis as Predictors of New-Onset Diabetes Mellitus in People With HIV: A Longitudinal Cohort Study.
Han WM; Apornpong T; Lwin HMS; Thammapiwan S; Boonrungsirisap J; Gatechompol S; Ubolyam S; Tangkijvanich P; Kerr SJ; Avihingsanon A
Clin Infect Dis; 2023 Dec; 77(12):1687-1695. PubMed ID: 37477514
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV.
Michel M; Labenz C; Wahl A; Anders M; Armandi A; Huber Y; Galle PR; Sprinzl M; Schattenberg JM
AIDS; 2022 Oct; 36(12):1665-1674. PubMed ID: 35849074
[TBL] [Abstract][Full Text] [Related]
4. Fibroscan-Aspartate Aminotransferase Score Predicts Liver-Related Outcomes, but Not Extrahepatic Events, in a Multicenter Cohort of People With Human Immunodeficiency Virus.
Sebastiani G; Milic J; Kablawi D; Gioè C; Al Hinai AS; Lebouché B; Tsochatzis E; Finkel J; Ballesteros LR; Ramanakumar AV; Bhagani S; Benmassaoud A; Mazzola G; Cascio A; Guaraldi G
Clin Infect Dis; 2023 Aug; 77(3):396-404. PubMed ID: 37013396
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysis.
Kalligeros M; Vassilopoulos A; Shehadeh F; Vassilopoulos S; Lazaridou I; Mylonakis E; Promrat K; Wands JR
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1708-1722. PubMed ID: 36642292
[TBL] [Abstract][Full Text] [Related]
6. NASH in HIV.
Cervo A; Shengir M; Patel K; Sebastiani G
Curr HIV/AIDS Rep; 2020 Dec; 17(6):601-614. PubMed ID: 32984925
[TBL] [Abstract][Full Text] [Related]
7. Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection.
Maurice JB; Goldin R; Hall A; Price JC; Sebastiani G; Morse CG; Prat LI; Perazzo H; Garvey L; Ingiliz P; Guaraldi G; Tsochatzis E; Lemoine M
Clin Infect Dis; 2021 Oct; 73(7):e2184-e2193. PubMed ID: 32877569
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies.
Agyapong G; Dashti F; Banini BA
Ann N Y Acad Sci; 2023 Aug; 1526(1):16-29. PubMed ID: 37400359
[TBL] [Abstract][Full Text] [Related]
9. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.
Krahn T; Martel M; Sapir-Pichhadze R; Kronfli N; Falutz J; Guaraldi G; Lebouche B; Klein MB; Wong P; Deschenes M; Ghali P; Sebastiani G
J Infect Dis; 2020 Aug; 222(5):787-797. PubMed ID: 32249283
[TBL] [Abstract][Full Text] [Related]
11. Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study.
Gawrieh S; Lake JE; Debroy P; Sjoquist JA; Robison M; Tann M; Akisik F; Bhamidipalli SS; Saha CK; Zachary K; Robbins GK; Gupta SK; Chung RT; Chalasani N; Corey KE
Hepatology; 2023 Aug; 78(2):578-591. PubMed ID: 36805976
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research.
Berardo C; Di Pasqua LG; Cagna M; Richelmi P; Vairetti M; Ferrigno A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348908
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
Roeb E; Geier A
Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
[TBL] [Abstract][Full Text] [Related]
14. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV.
Squillace N; Soria A; Bozzi G; Gori A; Bandera A
Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):643-650. PubMed ID: 31081390
[No Abstract] [Full Text] [Related]
17. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
Zhou JH; Cai JJ; She ZG; Li HL
World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.
Morse CG; McLaughlin M; Matthews L; Proschan M; Thomas F; Gharib AM; Abu-Asab M; Orenstein A; Engle RE; Hu X; Lempicki R; Hadigan C; Kleiner DE; Heller T; Kovacs JA
Clin Infect Dis; 2015 May; 60(10):1569-78. PubMed ID: 25681381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]